Wegovy vs Ozempic 2026: Same Drug, Very Different Situations

Wegovy and Ozempic are both semaglutide — the same active ingredient made by the same company (Novo Nordisk). But they’re not the same product, and the difference matters a lot depending on your goal, your insurance, and your budget. Here’s the complete comparison.

The Quick Answer

Ozempic is FDA-approved for type 2 diabetes at doses up to 2mg weekly. Wegovy is FDA-approved for chronic weight management at 2.4mg weekly. Same molecule — different approval, different dose, different insurance coverage, and very different pricing depending on your situation.

Head-to-Head Comparison

Factor	Ozempic	Wegovy
Active ingredient	Semaglutide	Semaglutide
FDA-approved for	Type 2 diabetes	Chronic weight management
Max approved dose	2mg/week	2.4mg/week
Injection frequency	Once weekly	Once weekly
Pen device	Pre-filled FlexTouch pen	Pre-filled auto-injector
Retail price (no insurance)	~$935/month	~$1,349/month
Insurance coverage for weight loss	Rarely (off-label)	Sometimes (when plan covers)
Average weight loss	~10–12% body weight (at 1mg)	~14.9% body weight (at 2.4mg)
Compounded version available?	Not typically (Ozempic-labeled)	Yes, widely (as compounded sema)

Why Wegovy Causes More Weight Loss

It’s about dose. Wegovy is titrated up to 2.4mg weekly — higher than the 0.5mg–2mg range used in Ozempic. More semaglutide means stronger appetite suppression and greater weight loss. The STEP 1 trial at 2.4mg showed 14.9% average body weight loss; Ozempic studies at 1mg showed about 6% weight loss.

This also means the side effect profiles are similar (same drug) but nausea and GI effects may be more pronounced at Wegovy’s higher dose, especially during titration.

Off-Label Ozempic for Weight Loss: What You Need to Know

Millions of people take Ozempic off-label for weight loss. It works — just not as dramatically as Wegovy at the higher dose. The reasons people do this:

• Insurance covers Ozempic for diabetes but not Wegovy for obesity — a frustrating but very common situation
• Availability — Wegovy has had more persistent supply issues in some regions
• Cost — Ozempic retail price is about 30% lower than Wegovy without insurance

However, if your goal is weight loss and you’re paying out of pocket, compounded semaglutide (the most common telehealth option) is almost always the better choice — same molecule as both Ozempic and Wegovy, but starting at $99–$249/month.

Insurance Coverage: The Key Difference

This is where Wegovy and Ozempic diverge most practically for most people:

• Ozempic + type 2 diabetes: Often covered by insurance. Prior auth usually required but approval rates are much higher when you have a diabetes diagnosis.
• Ozempic + weight loss only: Usually NOT covered. Most plans specifically exclude off-label obesity treatment.
• Wegovy + obesity: Coverage is expanding but still inconsistent. Employer plans are the most variable. Medicare Part D now covers Wegovy for obesity with cardiovascular disease (SELECT trial results drove this change). Medicaid coverage varies enormously by state.

Which Should You Choose?

Your Situation	Best Choice
Have type 2 diabetes, insurance covers it	Ozempic (or Mounjaro for better blood sugar control)
Want weight loss, insurance covers Wegovy	Wegovy
Want weight loss, paying out of pocket	Compounded semaglutide via telehealth ($99–249/mo)
Want maximum weight loss regardless of cost	Tirzepatide (Zepbound) — outperforms both
Insurance covers Ozempic but not Wegovy	Ozempic off-label (works but less effective at lower doses)

The Cheapest Way to Get Semaglutide for Weight Loss

For most people without insurance coverage, the answer isn’t Wegovy or Ozempic — it’s compounded semaglutide through a telehealth program. You get the same active molecule, physician oversight, and direct-to-door delivery at 80–90% lower cost than brand-name options.